Guangzhou, China – October 28, 2025 – Wondfo Biotech successfully concluded the Global POCT Summit 2025 in Guangzhou, China. Under the auspices of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the summit gathered leading healthcare professionals, laboratory experts, and industry stakeholders from more than 70 countries to explore emerging trends, technological innovation, and the future of POCT worldwide.
 

Prof. Jihua Wang, Founder and Chairwoman of Wondfo Biotech, welcomed international experts and partners, reaffirming Wondfo’s commitment to advancing diagnostic innovation through openness, collaboration, and continuous improvement.
 

Event Highlights: Advancing Point-of-Care Testing

The Global POCT Summit 2025 marked a significant gathering for the diagnostics community, featuring expert-led sessions and interactive panels.

· Inflammatory Markers and Antibiotic Stewardship: Experts from the Netherlands, Italy, and China showcased real-world POCT applications in infection management and antibiotic optimization across diverse clinical settings—from primary to critical care.

· Technology Breakthroughs in POCT: Specialists from South Africa, Sweden, and China explored innovations in thrombotic biomarkers, immunohistochemistry (IHC), and digital pathology, highlighting the clinical translation potential of new platforms, applications, and biomarkers.

· POCT in Cardiology and Critical Care: Global experts shared case studies including China's "Chest Pain Center Network," Norway's use of cardiac biomarkers in emergency departments, and Serbia's integration of NT-proBNP in heart failure prevention—illustrating POCT's indispensable role in cardiovascular care.



Background: Bridging Innovation and Clinical Practice

The Global POCT Summit is the inaugural event of the WondCare series, an initiative launched by Wondfo to strengthen collaboration between innovation and clinical practice. Rooted in the belief that every advancement in diagnostics should ultimately serve patients, WondCare represents Wondfo’s mission to bring diagnostic technologies closer to everyday healthcare.
 
Through this series, leading voices from diagnostics and clinical medicine come together to share knowledge, exchange ideas, and inspire innovation. WondCare serves as a platform where discovery meets application — transforming progress in IVD and POCT into measurable improvements in patient outcomes.
The Global POCT Summit 2025 kicks off this initiative with a special focus on inflammatory markers for antibiotic stewardship and cardiac markers for cardiovascular management. By fostering collaboration across disciplines — from laboratory medicine to primary and emergency care — the summit underscores Wondfo’s commitment to driving innovation beyond limits and improving healthcare outcomes worldwide.



Wondfo Biotech: Racing for life

Founded in 1992, Wondfo Biotech is a leading global provider of IVD (in vitro diagnostic) solutions, dedicated to making diagnostics more accessible, efficient, and reliable. Our comprehensive portfolio includes point-of-care testing (POCT), clinical laboratory, molecular diagnostics and more, offering integrated solutions for conditions such as cardiovascular diseases, diabetes, renal disorders, respiratory diseases, drug abuse, infectious diseases, etc.
 
Wondfo serves healthcare professionals in over 150 countries and regions. Racing for life, Wondfo is committed to safeguarding health worldwide. Guided by this mission, we continuously advance diagnostic technologies, delivering reliable solutions that support timely clinical decisions, enhance patient outcomes and contribute to the global advancement of healthcare.